Yep the consensus from brokers atm following dusk is zero growth in NPAT and about 5% growth in revenue a year moving to 2023. Hence prospects arn't that good unless you bought in sub $3 to return a 10% dividend. That being said DSK have proved the opposite many times and have continued to grow and increase revenue + NPAT every half. Hopefully the momentum keeps going.
The previous post is my conservative revenue estimate based on sales figures for the Jul to Aug (dates we have) and last xmas sales.
My bullish estimate is 99m to 105m for H1FY22
Conservative estimate 81m to 99m
Quit and find something else estimate <81m
Yep the consensus from brokers atm following dusk is zero growth...
Add DSK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
79.5¢ |
Change
0.015(1.92%) |
Mkt cap ! $49.50M | |||
| Open | High | Low | Value | Volume |
| 78.0¢ | 79.5¢ | 78.0¢ | $3.721K | 4.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12108 | 79.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.5¢ | 11348 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
79.0¢ |
Change
0.015 ( 1.28 %) |
||||
| Open | High | Low | Volume | ||
| 78.0¢ | 79.0¢ | 78.0¢ | 4562 | ||
| Last updated 15.15pm 03/05/2024 ? | |||||
| DSK (ASX) Chart |